Question 1
Which mode of action describes how theophylline affects cyclic AMP?
Correct Answer:
Prevents breakdown of cyclic AMP
Explanation:
Theophylline is primarily known for its role as a bronchodilator in the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Its mechanism of action involves the inhibition of phosphodiesterase enzymes, which are responsible for breaking down cyclic AMP (cAMP). By preventing the breakdown of cAMP, theophylline effectively increases its levels within cells, leading to enhanced relaxation of bronchial smooth muscle and improved airflow. Elevated cAMP levels have positive effects on bronchial dilation and can also exert anti-inflammatory effects. This mechanism contributes to the overall therapeutic effects of theophylline and helps to alleviate symptoms of airway obstruction. Therefore, the correct understanding of the mode of action of theophylline is that it prevents the breakdown of cyclic AMP, thus allowing for prolonged signaling and action within the respiratory tract.
Question 2
Which leukotriene receptor antagonist is widely used for asthma control?
Correct Answer:
Montelukast
Explanation:
Montelukast is the most widely used leukotriene receptor antagonist for asthma control due to its favorable safety profile, once-daily dosing convenience, and its effectiveness in reducing inflammation and bronchoconstriction associated with asthma. It specifically inhibits the action of leukotrienes, which are inflammatory mediators that can lead to bronchoconstriction and increased mucus production in asthma patients. Montelukast has been extensively studied and is a recommended option in asthma management guidelines for both adults and children, making it a common choice in clinical practice. While zafirlukast is another leukotriene receptor antagonist, it has less widespread use, primarily due to the need for more frequent dosing and potential liver toxicity. The name Singulair is the brand name for montelukast, which highlights its popularity further, but it is effectively the same medication. Asthalin, on the other hand, is a brand name for salbutamol (also known as albuterol), which is a short-acting beta-agonist used primarily for quick relief of asthma symptoms, rather than for long-term control. Thus, montelukast stands out as the leading choice in this category for asthma management.
Question 3
Which of the following is a side effect of all surfactants?
Correct Answer:
Bradycardia
Explanation:
Bradycardia is recognized as a potential side effect of all surfactants due to their impact on the cardiopulmonary system. Surfactants are administered primarily to manage conditions like respiratory distress syndrome in neonates, where their role is to reduce surface tension in the alveoli, promoting better lung function and oxygenation. The introduction of exogenous surfactants can influence cardiovascular responses, sometimes leading to a decrease in heart rate, or bradycardia. This response may be due to a combination of the drug effects, changes in lung mechanics, and altered gas exchange that surfactants facilitate. Hyperventilation is generally not a side effect associated with surfactant use. Instead, surfactants may actually stabilize the alveoli and lead to more efficient gas exchange. Dry cough is not a common direct effect of surfactants, although respiratory treatments can lead to cough due to irritation. Nausea can sometimes occur but is not as universally recognized across all surfactant preparations as bradycardia. Thus, bradycardia stands out as a more consistent and documented side effect across various surfactant agents.
Question 4
What route of administration is commonly used for leukotriene inhibitors?
Correct Answer:
Oral
Explanation:
Leukotriene inhibitors are primarily administered orally, making this the correct choice. This route is preferred for several reasons. First, oral administration allows for convenient dosing, as these medications are typically available in tablet or liquid form, making them easy for patients to take at home. Additionally, the oral route ensures that the drug is absorbed through the gastrointestinal tract into the systemic circulation, allowing for a longer duration of action and a steady therapeutic effect on leukotriene pathways, which are involved in inflammatory responses in conditions such as asthma and allergic rhinitis. By inhibiting leukotrienes, these medications help reduce bronchoconstriction, mucus production, and airway edema, which are key factors in respiratory conditions. Other routes like intravenous, inhalation, and subcutaneous are less common for leukotriene inhibitors. Intravenous administration is typically used for more immediate effects in acute situations, while inhalation is more suited for bronchodilators or corticosteroids that act directly on the lungs. Subcutaneous administration is also not standard for this class of medication, as it is not designed for quick systemic effects and is usually reserved for different types of therapies. Thus, the oral route aligns best with the pharmacological purpose and patient compliance for leukotriene inhibitors.
Question 5
Which of the following effects occurs due to the action of Beta-2 Agonists?
Correct Answer:
Bronchodilation
Explanation:
Beta-2 agonists are a class of medications primarily used in the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). These agents specifically target beta-2 adrenergic receptors located in the smooth muscle of the airways. When activated, these receptors lead to relaxation of these muscles, resulting in bronchodilation. This effect helps to widen the airways, improving airflow and making it easier for patients to breathe. In contrast, bronchoconstriction is a narrowing of the airways, which would oppose the action of beta-2 agonists. Increased histamine release typically contributes to bronchoconstriction and inflammation, which beta-2 agonists aim to counteract. Fluid retention is not directly related to the primary action of beta-2 agonists and is more associated with other classes of medications such as corticosteroids or certain antihypertensives. Therefore, the action of beta-2 agonists is specifically characterized by their ability to induce bronchodilation, making this the correct answer.
Question 1
Exam overview

About this Exam

The Respiratory Therapy Pharmacology Practice Exam is a comprehensive study resource designed for current and aspiring respiratory therapists (RTs). It focuses specifically on the extensive knowledge required regarding pulmonary and related medications used in patient care. This practice exam is ideal for students completing their respiratory care programs or individuals preparing for licensing exams, such as those administered by the National Board for Respiratory Care (NBRC), or aiming to advance their clinical expertise in pharmacological interventions. Mastery of these concepts is vital for ensuring safe and effective treatment plans for patients with acute and chronic respiratory conditions.

More details

Additional Information

What the Course Entails and Exam Details

This focused practice resource covers essential topics found in respiratory therapy pharmacology curricula. Key areas include the mechanisms of action, indications, contraindications, dosages, and common adverse effects for multiple drug classes. Candidates will delve into bronchodilators, corticosteroids, mast cell stabilizers, anticholinergics, anti-infective agents for pulmonary infections, pulmonary hypertension medications, surfactant, oxygen therapy as a drug, and aerosol delivery devices. Deep understanding of pharmacokinetics, pharmacodynamics, and clinical applications is tested. As this is a practice exam, it typically includes numerous multiple-choice questions meticulously crafted to simulate real-world scenarios and official test complexity.


What to Expect in the Final Exam

This practice exam mimics the structure and difficulty of licensing tests, often featuring approximately 50 to 100 multiple-choice questions focusing exclusively on pharmacology. Questions may be case-based, requiring critical thinking and clinical application, or direct knowledge recall concerning specific drug properties. Candidates may experience simulation elements for certain scenarios. There is typically a strict time limit per attempt, and a passing score equivalent (though purely for assessment) might set at around 70% or higher. Immediate feedback with detailed explanations for correct and incorrect answers is usually provided to enhance learning and pinpoint weaknesses.


How to Study and Exam Centers

Effective preparation for this comprehensive practice exam involves a multi-faceted approach. Students should thoroughly review standard respiratory care and pharmacology textbooks, clinical guidelines, and reliable online resources. Utilizing active recall methods like flashcards for drug classes and names is highly recommended. Consistently taking timed practice quizzes and full tests under simulated conditions will build confidence and improve time management. Creating visual aids like drug charts, maps, and flowcharts of mechanisms can also be extremely beneficial. This practice tool is typically accessed online through dedicated education portals or learning management systems. While this is an educational resource, official credentialing exams are often taken at standardized testing centers like Pearson VUE or other authorized venues, requiring separate registration.


Job Opportunities from the Course

A strong understanding of respiratory pharmacology is essential for unlocking a variety of career paths within healthcare. Successful mastery of this subject matter prepares individuals for key roles in various settings:

  • Registered Respiratory Therapist (RRT)

  • Certified Respiratory Therapist (CRT)

  • Critical Care Respiratory Therapist

  • Neonatal/Pediatric Respiratory Care Specialist

  • Pulmonary Function Technologist

  • Educational Coordinator (Respiratory Care Programs)

  • Respiratory Therapy Clinical Specialist

  • Industry Representative (e.g., Medical Devices, Pharmaceuticals)

  • Home Care Respiratory Therapist

  • Sleep Study Technician

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions